- Current report filing (8-K)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 22, 2010

 

 

CMS Bancorp Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		001-33322		20-8137247
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

123 Main Street, Suite 750 White Plains, New York		10601
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: [phone]

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 22, 2010, the Board of Directors (the “Board”) of CMS Bancorp, Inc. (the “Registrant”) voted to increase the size of the Board from eight directors to ten directors, with the additional directors to serve in the class with a term expiring at the annual meeting of shareholders to be held in 2011. The Board also elected Scott D. Hayworth, M.D. and Robert P. Weisz to the Board to fill the new directorships. Initially, Dr. Hayworth and Mr. Weisz will not be members of any committee of the Board. Dr. Hayworth and Mr. Weisz will be entitled to the same compensation as the other non-officer directors of the Registrant, including fees for attending board and committee meetings and eligibility to receive stock-based awards under the CMS Bancorp, Inc. 2007 Stock Option Plan and the CMS Bancorp, Inc. 2007 Recognition and Retention Plan. There are no transactions in which Dr. Hayworth or Mr. Weisz has an interest requiring disclosure under Item 404(a) of Regulation S-K. Dr. Hayworth and Mr. Weisz have also been appointed to the Board of Directors of Community Mutual Savings Bank, a wholly-owned subsidiary of the Registrant.

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

				CMS Bancorp Inc.
				(Registrant)
June 24, 2010				/s/ STEPHEN DOWD
(Date)				Stephen Dowd Senior Vice President and Chief Financial Officer